Phase 1: A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
Research Grant
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 19, 2026
End Date
April 30, 2027
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 19, 2026
End Date
April 30, 2027